Install
Zacks Small Cap Research coverage specifically looks to focus on small and micro-cap companies that are under followed or under valued by Wall Street.
- 38articles · 30d
- 3+ day agolatest article
- Aug 17, 2026earliest in window
- 0%with images
- 298avg words
- Economy, Business & Finance 33
- Finance & Business 25
- News 21
- Health & Wellness 10
- Medical 8
- Business & Industrial 6
- Industrial 5
- Health 4
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
GOTRF: Surebet Discovery Site Visit confirms our positive outlook for the project. Drilling continues to hit mineralization, expand the footprint, and remains open.
3+ day, 21+ hour ago (522+ words) //s27.q4cdn.com/906368049/files/pictures/2026/09102026_GOTRF_1.png GOTRF: Surebet Discovery Site Visit confirms our positive outlook for the project. Drilling continues to hit mineralization, expand the footprint, and remains open. In August 2026, the analyst travelled to northern British Columbia to conduct a due…...
MTVA: Preclinical Findings Support DA-1726 Waist Circumference Reduction
3+ day, 21+ hour ago (1108+ words) By David Bautz, PhD NASDAQ: MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Preclinical Results Provide Insight into DA-1726 Mechanism of Waist Reduction On September 9, 2026, MetaVia, Inc. (NASDAQ: MTVA) announced the results of a preclinical study utilizing radioactively labeled…...
BDMD: Baird Medical Reports Strong Revenue Growth for the 6-Month Period Ending 6/30/26
4+ day, 43+ min ago (274+ words) By Tom Kerr, CFA READ THE FULL BDMD RESEARCH REPORT On September 3, 2026, Baird Medical (NASDAQ: BDMD) released financial results for the 6-month period ending June 30, 2026, which showed strong revenue growth from non-China regions. Cash level profitability also improved significantly. EBITDA…...
CPKF Posts Another Strong Quarter with Diluted EPS Up 75% Year over Year
5+ day, 1+ hour ago (278+ words) By Ann Heffron, CFA, CPA READ THE FULL CPKF RESEARCH REPORT Chesapeake Financial (OTCQX: CPKF) produced another strong quarter with 2026 second quarter net earnings surging $2.3 million, or 74%, to $5.5 million year over year, while 2026’s second quarter diluted EPS rose $0.50, or…...
LEXX: Introducing DehydraTECH 3.0
6+ day ago (868+ words) //s27.q4cdn.com/906368049/files/pictures/2026/09082026_LEXX_1.png LEXX: Introducing DehydraTECH 3.0 Lexaria Bioscience Corp. (NASDAQ: LEXX) announced absorption data from its 2026 Animal Study #2 (GLP-1-A26-2). The canine study examined amycretin and retatrutide bioavailability using oral delivery compared to reference formats. 18 different study arms were evaluated,…...
UHAL: U-Haul Reported 1Q FY2027 Financial Results
6+ day, 30+ min ago (334+ words) By Steven Ralston, CFA READ THE FULL UHAL RESEARCH REPORT On August 20, 2026, U-Haul held its 20th Annual Virtual Analyst and Investor Meeting, which was largely composed of answering analyst and investor questions. Highlights from the 20th Annual Virtual Analyst & Investor Meeting Toy…...
CTSO: CytoSorbents Announces Very Positive New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor
1+ week, 4+ day ago (97+ words) By Tom Kerr, CFA READ THE FULL CTSO RESEARCH REPORT New Findings Presented at European Society of Cardiology (ESC) Congress 2026 FDA Pre-Submission Meetings with FDA Based on 2nd quarter 2026 results and management commentary, we adjust our full year 2026 revenue estimate to…...
BENF: Beneficient Releases 1st Fiscal Quarter Results (Period Ending 6/30/26)
1+ week, 4+ day ago (376+ words) By Tom Kerr, CFA READ THE FULL BENF RESEARCH REPORT 1st Quarter 2027 Results (period ending June 30, 2026) On August 14, 2026, Beneficient (NASDAQ: BENF) announced fiscal 1st quarter results for the period ending 6/30/26. Beneficient reported $212.5 million of investments at fair value as of June 30, 2026, up…...
TNXP: $11.0 Million in Tonmya® Net Revenue in 2Q26
1+ week, 4+ day ago (233+ words) READ THE FULL TNXP RESEARCH REPORT $11.0 Million in Net Revenue for Tonmya® in 2Q26 Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is continuing the commercial launch of Tonmya® following its approval in August 2025 and commercial launch in November 2025. Sales metrics for the…...
CVKD: Advancing Partnering Process for Cardiac Acute Critical Care Franchise
1+ week, 6+ day ago (166+ words) READ THE FULL CVKD RESEARCH REPORT Launches Strategic Partnering Process for Cardiac Acute Critical Care Franchise Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) has launched a structured strategic partnering process for its Cardiac Acute Critical Care Franchise that is centered on three…...